New test could simplify the diagnosis of coeliac disease

January 13, 2014, Walter and Eliza Hall Institute
New test could simplify the diagnosis of coeliac disease
This shows Dr. Jason Tye-Din, Ms. Cathy Pizzey, Mr. Adam Girardin, and Dr. Melinda Hardy (left to right) from the Walter and Eliza Hall Institute are developing a new blood test to diagnose coeliac disease. Credit: Walter and Eliza Hall Institute

A new blood test being developed by Walter and Eliza Hall Institute researchers can rapidly and accurately diagnose coeliac disease without the need for prolonged gluten exposure.

Dr Jason Tye-Din, gastroenterologist and head of coeliac research at the Walter and Eliza Hall Institute, said the new diagnostic test gave a result within 24 hours and preliminary findings indicated it could accurately detect coeliac disease. It is hoped that larger studies will verify its role as a widely used tool for diagnosing coeliac disease.

"Current diagnosis of coeliac disease is limited by the need for intestinal biopsies and patients to be eating gluten," Dr Tye-Din said. "For the many people who follow gluten-free diets without a formal diagnosis, reliable testing for coeliac disease requires them to consume gluten again, which is often unpleasant and difficult."

Researchers from the Melbourne institute, with colleagues from biotechnology company ImmusanT in Boston, US, led a study of the in 48 participants, the results of which were published in the journal Clinical & Experimental Immunology.

"Our findings reveal this novel blood test is accurate after only three days of gluten consumption, not the several weeks or months traditionally required to make a diagnosis using intestinal biopsies," Dr Tye-Din said.

Coeliac disease is caused by an abnormal immune (T cell) reaction to gluten in the diet, leading to damage to the small intestine. It can cause digestive symptoms such as nausea, vomiting, bloating, and diarrhoea, as well as lethargy, anaemia, headaches and weight loss. As many as one in 60 women and one in 80 men in Australia have coeliac disease, but four out of five remain undiagnosed.

Dr Tye-Din said that the blood test built on fundamental research discoveries the team had made about coeliac disease. "This 'cytokine release' test measures the T cell response to gluten after three days of consumption, and a positive response is highly predictive of coeliac disease," he said. "With this test, we were able to detect a T cell response in the majority of study participants known to have coeliac disease and importantly, the test was negative in all of the patients who did not have coeliac disease, even though they followed a gluten-free diet and thought gluten was the cause of their symptoms."

Dr Tye-Din said that many 'gluten sensitive' people found it distressing to reintroduce gluten into their diet in order to be tested properly for coeliac disease. "People are fearful about experiencing unpleasant symptoms and end up stopping prematurely or avoiding testing altogether," he said.

"A test that simplifies diagnosis for patients is likely to significantly enhance disease detection. This new diagnostic approach is encouraging and we hope that larger studies can validate these findings and establish its role in the diagnosis of coeliac disease, with the possibility of avoiding intestinal biopsies for diagnosis altogether."

Dr Bob Anderson, chief scientific officer at ImmusanT, said that the blood test could also assist in the monitoring of a therapeutic vaccine for coeliac disease. "This is an important step toward a tool that could monitor changes in the small population of circulating T cells responsible for coeliac disease when using treatments intended to restore tolerance to gluten, such as Nexvax2®, the compound currently being developed by ImmusanT," Dr Anderson said.

Dr Tye-Din said it was important for people following a -free diet to be properly tested for . "Coeliac disease can lead to significant long-term complications such as malnutrition, osteoporosis, infertility, pregnancy issues, liver failure, infection and cancer, so it is essential that people with this illness are diagnosed and treated to reduce these complications," he said.

Explore further: New approach to celiac testing identifies more Australians at risk

Related Stories

New approach to celiac testing identifies more Australians at risk

August 27, 2013
Australian researchers have developed a new approach to detecting coeliac disease, revealing this immune disorder is far more common than previously recognised.

Research gives new insight into coeliac disease

October 11, 2012
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.

Celiac disease vaccine shows promising results in Phase I trial

May 9, 2011
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.

Digestive disorder reaches record levels in Scots children

September 17, 2013
More children than ever before are living with a debilitating digestive disease, research has shown.

Recommended for you

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.